Page 10 - Johnson & Johnson

Johnson & Johnson says to buy pharma group Actelion for $30 bn

Deal will create a new Swiss-listed firm called R&D NewCo ocusing on the R&D of new drugs

Johnson & Johnson in talks to buy Actelion

A deal could be finalised by late January

Johnson & Johnson ordered to pay $1 billion for faulty hip implants

J&J still faces almost 9,000 lawsuits accusing the company of mishandling the metal-on-metal hips

Johnson & Johnson in talks to buy Actelion for $17 billion

An acquisition would add to the $246 billion of pharmaceutical deals announced this year

Johnson & Johnson warns diabetic patients: Insulin pump vulnerable to hacking

It is the first time a manufacturer had issued such a warning to patients about a cyber vulnerability

Johnson & Johnson told to pay $55 mn in talc-powder trial

The company is facing nearly 1,200 lawsuits

J&J loses second talcum powder case, ripples may be felt in India

Firm says it will appeal the verdict

Regulators to inspect J&J's factory

To investigate alleged carcinogenic effect and presence of impurities in baby powder

Maharashtra FDA sends Johnson & Johnson baby powder for lab tests

The move comes months after a 62-year old woman in the US died of ovarian cancer linked to sustained use of the powder

Big verdict doesn't assure more wins for plaintiffs in talc-cancer cases

Jacqueline Fox was awarded $72 million by a St Louis jury in J&J case

Johnson & Johnson asked to pay $72 million in damages for cancer-causing talcum powder

An Alabama woman died from ovarian cancer, which she said was caused by using Johnson & Johnson's baby powder